Sign in

CIK 0000899460

  • Large accelerated filer

MANNKIND CORP

Sign in to watch
Ticker
MNKD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133607736
Phone
+1 818-661-5000
Business address
1 CASPER STREET, DANBURY, CT, 06810
  1. 4 Grant or award Chief Executive Officer acquired 565,000 shares (grant or award)
  2. 4 Grant or award EVP Endocrine Business Unit acquired 200,000 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award EVP Genl Counsel & Secretary acquired 200,000 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award Chief People & Workpl Officer acquired 200,000 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award Chief Technology Officer acquired 200,000 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Chief Commercial Officer bought 36,900 shares at $2.71 ($99,999)
  16. 4 Open-market buy Director bought 40,000 shares at $2.71 ($108,400)
  17. 4 Open-market buy Director bought 27,675 shares at $2.71 ($74,999)
  18. 4 Open-market buy Chief People & Workpl Officer bought 9,225 shares at $2.71 ($25,000)
  19. 4 Open-market buy Chief Executive Officer bought 27,675 shares at $2.71 ($74,999)
  20. 4 Open-market buy Director bought 110,701 shares at $2.71 ($300,000)

Page 12 of 50 · 999 filings